BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35246422)

  • 1. Prediction models for venous thromboembolism in ambulatory adults with pancreatic and gastro-oesophageal cancer: protocol for systematic review and meta-analysis.
    Zaheer A; Naumovski N; Toohey K; Niyonsenga T; Yip D; Brown N; Mortazavi R
    BMJ Open; 2022 Mar; 12(3):e056431. PubMed ID: 35246422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Models for predicting venous thromboembolism in ambulatory patients with lung cancer: a systematic review protocol.
    Yan AR; Samarawickrema I; Naunton M; Peterson GM; Yip D; Mortazavi R
    BMJ Open; 2021 Dec; 11(12):e055322. PubMed ID: 34853112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of venous thromboembolism in patients undergoing gastric cancer surgery: protocol for a systematic review and meta-analysis.
    Wang D; Yu Y; Tao P; Wang D; Chen Y; Chen H
    BMJ Open; 2020 Jan; 10(1):e033267. PubMed ID: 31919125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE.
    Ensor J; Riley RD; Moore D; Bayliss S; Jowett S; Fitzmaurice DA
    Syst Rev; 2013 Oct; 2():91. PubMed ID: 24089702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of tissue factor in patients with pancreatic cancer: a systematic review protocol.
    Li H; Yu Y; Shi Q; Chen X; Zheng P; Wang D; Tao P; Gu B; Li X; Zhang T; Xiang L; Xi D; Gao L; Maswikiti Ewetse P; Chen H
    BMJ Open; 2020 Sep; 10(9):e037431. PubMed ID: 32928856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
    Sterne JA; Bodalia PN; Bryden PA; Davies PA; López-López JA; Okoli GN; Thom HH; Caldwell DM; Dias S; Eaton D; Higgins JP; Hollingworth W; Salisbury C; Savović J; Sofat R; Stephens-Boal A; Welton NJ; Hingorani AD
    Health Technol Assess; 2017 Mar; 21(9):1-386. PubMed ID: 28279251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis.
    Khan F; Rahman A; Carrier M; Kearon C; Schulman S; Couturaud F; Prandoni P; Eichinger S; Becattini C; Agnelli G; Büller HR; Brighton TA; Palareti G; Pinede L; Sabri E; Hutton B; Wells GA; Rodger MA;
    BMJ Open; 2017 Sep; 7(9):16950. PubMed ID: 28939565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of novel oral anticoagulants for the treatment of cancer-associated venous thromboembolism: protocol for an umbrella review of systematic reviews and meta-analyses.
    Xia Y; Tang L; Hu Y
    BMJ Open; 2023 Apr; 13(4):e066853. PubMed ID: 37024258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Rutjes AW; Porreca E; Candeloro M; Valeriani E; Di Nisio M
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD008500. PubMed ID: 33337539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of venous thromboembolism in people with active tuberculosis: a systematic review and meta-analysis protocol.
    Awana PA; Danwang C; Tochie JN; Bigna JJ
    BMJ Open; 2019 Nov; 9(11):e031402. PubMed ID: 31722945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation.
    Ensor J; Riley RD; Jowett S; Monahan M; Snell KIe; Bayliss S; Moore D; Fitzmaurice D;
    Health Technol Assess; 2016 Feb; 20(12):i-xxxiii, 1-190. PubMed ID: 26879848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
    Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world adherence to oral anticoagulants in atrial fibrillation patients: a study protocol for a systematic review and meta-analysis.
    Rodríguez-Bernal CL; García-Sempere A; Hurtado I; Santa-Ana Y; Peiró S; Sanfélix-Gimeno G
    BMJ Open; 2018 Dec; 8(12):e025102. PubMed ID: 30573490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE.
    Ensor J; Riley RD; Moore D; Snell KI; Bayliss S; Fitzmaurice D
    BMJ Open; 2016 May; 6(5):e011190. PubMed ID: 27154483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer.
    Fuentes HE; Oramas DM; Paz LH; Casanegra AI; Mansfield AS; Tafur AJ
    Thromb Res; 2017 Jun; 154():28-34. PubMed ID: 28402864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre.
    Pelletier R
    J Oncol Pharm Pract; 2021 Jun; 27(4):911-918. PubMed ID: 33757321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness, reach, uptake and feasibility of digital health interventions for adults with venous thromboembolism: protocol of a systematic review and meta-analysis.
    Fu Y; Pu H; Wang Y; Lu X; Qiu P; Hu M; Cheng Y
    BMJ Open; 2024 Mar; 14(3):e074547. PubMed ID: 38548369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body size measures and risk of venous thromboembolism: protocol for a systematic review and meta-analysis.
    Kaze AD; Bigna JJ; Nansseu JR; Noubiap JJ
    BMJ Open; 2018 Mar; 8(3):e018958. PubMed ID: 29605820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
    Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
    JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.